liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers
Regional Pharmacovigilance Unit, Clinical Pharmacology, Lund University Hospital, Lund, Sweden.
Linköping University, Department of Medical and Health Sciences, Clinical Pharmacology. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Centre for Diagnostics, Department of Clinical Pharmacology.
Centre for Pharmacoepidemiology, Karolinska Institute, Stockholm, Sweden.
Regional Pharmacovigilance Unit, Clinical Pharmacology, Lund University Hospital, Lund, Sweden.
2010 (English)In: Drug, Healthcare and Patient Safety, ISSN 1179-1365, Vol. 2, 21-25 p.Article in journal (Refereed) Published
Abstract [en]

Aim: To describe spontaneously reported cases of erectile dysfunction (ED) in association with angiotensin II type I blockers (ARB) and other antihypertensive drugs.

Subjects and methods: All spontaneously reported cases of ED submitted to the Swedish Medical Products Agency (MPA) between 1990 and 2006, where at least one antihypertensive drug was the suspected agent, were scrutinized. Patient demographics, drug treatment and adverse reactions were recorded. Using the Bayesian Confidence Propagation Neural Network (BCPNN) method, the information component (IC) was calculated.

Results: Among a total of 225 reports of ED, 59 involved antihypertensive drugs including ARB (9 cases) as suspected agents. A positive IC value was found indicating that ED was reported more often in association with antihypertensive drugs classes, except for angiotensin-converting enzyme inhibitors, compared with all other drugs in the database. Positive dechallenge was reported in 43 cases (72%).

Discussion: All classes of major antihypertensive drugs including ARB were implicated as suspected agents in cases of ED. Few risk factors were identified. The relatively high reporting of ED in association with ARB is in contrast with previous studies, suggesting that ARB have neither a positive nor any effect on ED. This discrepancy suggests that further studies are warrnted on this potential adverse reaction to ARB.

Place, publisher, year, edition, pages
United States: Dove Press , 2010. Vol. 2, 21-25 p.
Keyword [en]
Drug, Healthcare and Patient Safety
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-54789OAI: diva2:309865
Available from: 2010-04-09 Created: 2010-04-09 Last updated: 2011-05-13

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Hägg, Staffan
By organisation
Clinical PharmacologyFaculty of Health SciencesDepartment of Clinical Pharmacology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 63 hits
ReferencesLink to record
Permanent link

Direct link